Morgan Stanley Downgrades Ionis Pharmaceuticals to Underweight

Morgan Stanley downgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Equal-Weight to Underweight.

Benzinga · 11/07/2019 11:39

Morgan Stanley downgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Equal-Weight to Underweight.